Melanoma and basal cell carcinoma in the hereditary leiomyomatosis and renal cell cancer syndrome. An expansion of the oncologic spectrum.
[摘要] BackgroundHereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) is an autosomal dominant syndrome due to mutation in fumarate hydratase. Patients with HLRCC frequently develop cutaneous and uterine leiomyomata and are at risk for renal cell carcinoma. Rarely, other malignancies have been reported.Main observationsWe report the development of basal cell carcinoma and melanoma in two siblings with genetically-confirmed HLRCC.ConclusionsIt is unclear whether the development of melanoma and basal cell carcinoma in our patients is due directly to their mutations in the gene encoding fumarate hydratase, or genetic susceptibility at another unrelated locus, or whether these are incidental lesions. However this observation has implications for careful and routine skin surveillance in patients with HLRCC for lesions other than cutaneous leiomyomata.
[发布日期] [发布机构]
[效力级别] [学科分类] 皮肤病学
[关键词] basal cell carcinoma;fumarate hydratase;leyomyoma;renal cell cancer;skin cancer;melanoma [时效性]